SUNNYVALE, Calif., June 16, 2010 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTCBB:ARYC), a leader in life sciences and healthcare technology, reports today that the company has installed its patented and proprietary NanoPrint™ LM60 Enterprise Level Microarrayer at the Commonwealth Scientific and Industrial Research Organization (CSRIO) in Hobart, Tasmania, Australia. The CSRIO is supplementing its next generation sequencing technology with the Arrayit microarray platform for additional speed, throughput and affordability.
Arrayit's microarray platform empowers the CSRIO to manufacture microarrays, glass substrates or "chips" containing microscopic DNA spots that enable the rapid identification of bacteria and other microbes present in the Indian Ocean and Tasman Sea. The Environmental Genomics Team at the Marine and Atmospheric Research and Wealth from Oceans, National Research Flagship is seeking to advance microbial genomics by pin-pointing the critical role hundreds of different microorganisms play in various ocean sub-environments. Oceanic microbes sustain life on earth by providing oxygen, nutrients and bioremediation functions at all ocean depths including the ocean floor.
Arrayit Corporation Executive Todd Martinsky said, "We are pleased that CSRIO chose NanoPrint™ to further oceanic microbial research. This information is vital to global ecology including understanding and implementing the most efficient means of remediating the oil spill in the Gulf of Mexico." Arrayit Corporation President Dr. Mark Schena added, "Ocean bacteria naturally degrade millions of metric tons of oil each year by converting hydrocarbons seeping from the ocean floor into harmless CO2 and H2O. Arrayit is proud to facilitate scientific research into natural processes such as these that are keys to neutralizing massive ecological challenges."About Arrayit Corporation Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. Arrayit now offers over 650 products and services to a customer base of more than 10,000 clinics and research facilities and more than 5,000 laboratories worldwide, including most every major university, pharmaceutical and biotech company, major agricultural and chemical company, government agency, national research foundation and many private sector enterprises. Please visit www.arrayit.com for more information. Safe Harbor Statement We have identified forward-looking statements by using words such as "expect," "believe," and "should." Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-K for the fiscal year ended December 31, 2009 and Form 10-Q for the quarter ended March 31, 2010.
CONTACT: Arrayit Corporation Investor Relations 408-744-1331 firstname.lastname@example.org